Karen Ouyang

888 total citations · 1 hit paper
17 papers, 244 citations indexed

About

Karen Ouyang is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Karen Ouyang has authored 17 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Karen Ouyang's work include Genomics and Rare Diseases (5 papers), BRCA gene mutations in cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Karen Ouyang is often cited by papers focused on Genomics and Rare Diseases (5 papers), BRCA gene mutations in cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Karen Ouyang collaborates with scholars based in United States, Chile and Singapore. Karen Ouyang's co-authors include Swaroop Aradhya, Susan Rojahn, Keith Nykamp, Edward D. Esplin, Scott T. Michalski, Erin O’Leary, Kathryn E. Hatchell, Britt Johnson, Jennifer Holle and Shan Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Karen Ouyang

17 papers receiving 243 citations

Hit Papers

Rates and Classification of Variants of Uncertain Signifi... 2023 2026 2024 2025 2023 25 50 75

Peers

Karen Ouyang
Hélene Schlecht United Kingdom
Se Song Jang South Korea
Jana Gutwein Germany
Mitchell W. Dillon United States
Loreall Pooler United States
Hélene Schlecht United Kingdom
Karen Ouyang
Citations per year, relative to Karen Ouyang Karen Ouyang (= 1×) peers Hélene Schlecht

Countries citing papers authored by Karen Ouyang

Since Specialization
Citations

This map shows the geographic impact of Karen Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Ouyang more than expected).

Fields of papers citing papers by Karen Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Ouyang. The network helps show where Karen Ouyang may publish in the future.

Co-authorship network of co-authors of Karen Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Ouyang. A scholar is included among the top collaborators of Karen Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Ouyang. Karen Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wilde, Blake R., Daiki Ueno, Edward D. Esplin, et al.. (2023). FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer. Cancer Discovery. 13(9). 2072–2089. 19 indexed citations
2.
Truty, Rebecca, Susan Rojahn, Karen Ouyang, et al.. (2023). Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals. The American Journal of Human Genetics. 110(4). 551–564. 8 indexed citations
3.
Lu, Eric, Paul C. Boutros, Liying Zhang, et al.. (2023). Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma. Urology. 176. 106–114. 6 indexed citations
4.
Chen, Elaine, Flavia M. Facio, Susan Rojahn, et al.. (2023). Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing. JAMA Network Open. 6(10). e2339571–e2339571. 78 indexed citations breakdown →
5.
Johnson, Britt, Karen Ouyang, Lauren B. Frank, et al.. (2022). Systematic use of phenotype evidence in clinical genetic testing reduces the frequency of variants of uncertain significance. American Journal of Medical Genetics Part A. 188(9). 2642–2651. 14 indexed citations
6.
Lu, Eric, Kathryn E. Hatchell, Sarah M. Nielsen, et al.. (2021). Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer. 128(4). 675–684. 16 indexed citations
7.
Truty, Rebecca, Karen Ouyang, Susan Rojahn, et al.. (2021). Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation. The American Journal of Human Genetics. 108(4). 696–708. 38 indexed citations
8.
Tahiliani, Jackie, et al.. (2020). Utility of RNA Sequencing Analysis in the Context of Genetic Testing. 8(4). 140–146. 5 indexed citations
9.
Truty, Rebecca, Karen Ouyang, Michelle K. Zeman, et al.. (2019). Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia. The Journal of Pediatrics. 215. 172–177.e2. 1 indexed citations
10.
Celestino-Soper, Patrícia B. S., Lili Zhang, Karen Ouyang, et al.. (2018). Genetic analyses in a bonobo (Pan paniscus) with arrhythmogenic right ventricular cardiomyopathy. Scientific Reports. 8(1). 4350–4350. 3 indexed citations
11.
Yang, Sherry X., Karen Ouyang, Karl F. Erhard, et al.. (2018). Abstract P4-06-02: Germline analysis of breast cancer patients with abnormal somatic results: Ancillary assessment or critical co-diagnostic?. Cancer Research. 78(4_Supplement). P4–6. 1 indexed citations
12.
Andersen, Erica, Rachel D. Burnside, Bradley P. Coe, et al.. (2018). 28. Dosage sensitivity curation of recurrent copy number variant regions. Cancer Genetics. 224-225. 61–61. 1 indexed citations
13.
O’Leary, Erin, Jennifer Holle, Scott T. Michalski, et al.. (2017). Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk. Annals of Surgical Oncology. 24(10). 3060–3066. 47 indexed citations
14.
Yang, Shan, Scott T. Michalski, Jennifer Holle, et al.. (2017). Unexpected germline mutations in a pan-cancer analysis including sarcoma, renal, and other cancers.. Journal of Clinical Oncology. 35(15_suppl). 1584–1584. 1 indexed citations
15.
Sorscher, Steven, Rodwige J. Desnoyers, Karen Ouyang, & Shakti Ramkissoon. (2017). Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes. The Oncologist. 22(9). 1084–1085. 1 indexed citations
16.
Ouyang, Karen, et al.. (2015). Intermediate MCAD Deficiency Associated with a Novel Mutation of theACADMGene: c.1052C>T. SHILAP Revista de lepidopterología. 2015. 1–4. 2 indexed citations
17.
Madrid, Andrés Morales La, Karen Ouyang, Gordana Raca, et al.. (2012). Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression. Pediatric Blood & Cancer. 60(2). 332–335. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026